vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and Employers Holdings, Inc. (EIG). Click either name above to swap in a different company.
AVANOS MEDICAL, INC. is the larger business by last-quarter revenue ($180.9M vs $170.5M, roughly 1.1× Employers Holdings, Inc.). On growth, AVANOS MEDICAL, INC. posted the faster year-over-year revenue change (0.7% vs -21.3%). Over the past eight quarters, AVANOS MEDICAL, INC.'s revenue compounded faster (4.4% CAGR vs -11.4%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
Employers Holdings, Inc. is a U.S.-headquartered insurance holding company that specializes in offering workers' compensation insurance and customized risk management services primarily for small and medium-sized enterprises across the United States. It mainly serves clients in low-to-medium hazard industries, helping them mitigate workplace safety risks and meet relevant regulatory requirements for employee protection.
AVNS vs EIG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $170.5M |
| Net Profit | $-1.3M | — |
| Gross Margin | 47.5% | — |
| Operating Margin | 1.4% | — |
| Net Margin | -0.7% | — |
| Revenue YoY | 0.7% | -21.3% |
| Net Profit YoY | 99.7% | — |
| EPS (diluted) | $-0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $170.5M | ||
| Q4 25 | $180.9M | $188.5M | ||
| Q3 25 | $177.8M | $239.3M | ||
| Q2 25 | $175.0M | $246.3M | ||
| Q1 25 | $167.5M | $202.6M | ||
| Q4 24 | $179.6M | $216.6M | ||
| Q3 24 | $170.4M | $224.0M | ||
| Q2 24 | $171.7M | $217.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-1.3M | — | ||
| Q3 25 | $-1.4M | $-8.3M | ||
| Q2 25 | $-76.8M | $29.7M | ||
| Q1 25 | $6.6M | $12.8M | ||
| Q4 24 | $-397.3M | — | ||
| Q3 24 | $4.3M | $30.3M | ||
| Q2 24 | $1.8M | $31.7M |
| Q1 26 | — | — | ||
| Q4 25 | 47.5% | — | ||
| Q3 25 | 48.4% | — | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.6% | — | ||
| Q4 24 | 54.6% | — | ||
| Q3 24 | 54.5% | — | ||
| Q2 24 | 55.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | — | ||
| Q3 25 | 0.1% | -4.7% | ||
| Q2 25 | -42.6% | 15.0% | ||
| Q1 25 | 6.1% | 7.8% | ||
| Q4 24 | -233.0% | — | ||
| Q3 24 | 7.0% | 16.4% | ||
| Q2 24 | 3.7% | 18.4% |
| Q1 26 | — | — | ||
| Q4 25 | -0.7% | — | ||
| Q3 25 | -0.8% | -3.5% | ||
| Q2 25 | -43.9% | 12.1% | ||
| Q1 25 | 3.9% | 6.3% | ||
| Q4 24 | -221.2% | — | ||
| Q3 24 | 2.5% | 13.5% | ||
| Q2 24 | 1.0% | 14.6% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.02 | $-0.93 | ||
| Q3 25 | $-0.03 | $-0.36 | ||
| Q2 25 | $-1.66 | $1.23 | ||
| Q1 25 | $0.14 | $0.52 | ||
| Q4 24 | $-8.64 | $1.14 | ||
| Q3 24 | $0.09 | $1.21 | ||
| Q2 24 | $0.04 | $1.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $169.9M |
| Total DebtLower is stronger | $90.3M | — |
| Stockholders' EquityBook value | $778.2M | $955.7M |
| Total Assets | $1.1B | $3.4B |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $169.9M | ||
| Q4 25 | $89.8M | $169.9M | ||
| Q3 25 | $70.5M | $172.4M | ||
| Q2 25 | $90.3M | $78.1M | ||
| Q1 25 | $97.0M | $100.4M | ||
| Q4 24 | $107.7M | $68.4M | ||
| Q3 24 | $89.0M | $173.9M | ||
| Q2 24 | $92.2M | $126.4M |
| Q1 26 | — | — | ||
| Q4 25 | $90.3M | $19.0M | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $95.7M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | $125.3M | $0 | ||
| Q3 24 | $152.6M | — | ||
| Q2 24 | $164.9M | — |
| Q1 26 | — | $955.7M | ||
| Q4 25 | $778.2M | $955.7M | ||
| Q3 25 | $778.0M | $1.0B | ||
| Q2 25 | $776.3M | $1.1B | ||
| Q1 25 | $839.4M | $1.1B | ||
| Q4 24 | $828.5M | $1.1B | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $1.2B | $1.0B |
| Q1 26 | — | $3.4B | ||
| Q4 25 | $1.1B | $3.4B | ||
| Q3 25 | $1.1B | $3.5B | ||
| Q2 25 | $1.0B | $3.5B | ||
| Q1 25 | $1.1B | $3.6B | ||
| Q4 24 | $1.2B | $3.5B | ||
| Q3 24 | $1.7B | $3.6B | ||
| Q2 24 | $1.7B | $3.5B |
| Q1 26 | — | — | ||
| Q4 25 | 0.12× | 0.02× | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | 0.00× | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.13× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | — |
| Free Cash FlowOCF − Capex | $21.3M | — |
| FCF MarginFCF / Revenue | 11.8% | — |
| Capex IntensityCapex / Revenue | 3.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $28.2M | $44.7M | ||
| Q3 25 | $14.0M | $29.4M | ||
| Q2 25 | $6.8M | $0 | ||
| Q1 25 | $25.7M | $14.6M | ||
| Q4 24 | $57.9M | $76.4M | ||
| Q3 24 | $23.0M | $51.0M | ||
| Q2 24 | $27.8M | $11.7M |
| Q1 26 | — | — | ||
| Q4 25 | $21.3M | $44.6M | ||
| Q3 25 | $7.0M | — | ||
| Q2 25 | $-4.2M | — | ||
| Q1 25 | $19.0M | — | ||
| Q4 24 | $53.1M | $76.3M | ||
| Q3 24 | $20.0M | — | ||
| Q2 24 | $21.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | 11.8% | 23.7% | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | -2.4% | — | ||
| Q1 25 | 11.3% | — | ||
| Q4 24 | 29.6% | 35.2% | ||
| Q3 24 | 11.7% | — | ||
| Q2 24 | 12.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.8% | 0.1% | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | 6.3% | — | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 2.7% | 0.0% | ||
| Q3 24 | 1.8% | — | ||
| Q2 24 | 3.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | 3.89× | 1.14× | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.35× | 1.68× | ||
| Q2 24 | 15.44× | 0.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
EIG
Segment breakdown not available.
